LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

LLY

891.61

+0.7%↑

NVO

140.76

+0.14%↑

UNH

480.58

-1.8%↓

JNJ

145.68

-0.23%↓

MRK

127.92

+0.24%↑

Search

Arbutus Biopharma Corp

Closed

3.01 -1.95

Overview

Share price change

24h

Current

Min

3.01

Max

3.03

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+38.89 upside

Dividends

By Dow Jones

Next Earnings

1 sie 2024

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Arbutus Biopharma Corp Chart

Related News

18 cze 2024, 19:25 UTC

Acquisitions, Mergers, Takeovers

Nvidia in Deal to Buy Software Startup Shoreline.io, Bloomberg Reports

18 cze 2024, 15:42 UTC

Acquisitions, Mergers, Takeovers

Circle K, Global Partners Sell Dozens of U.S. Stores -- OPIS

18 cze 2024, 21:36 UTC

Market Talk

Fitch Affirms Canadian Bank Ratings, Citing Pending BOC Rate Cuts -- Market Talk

18 cze 2024, 20:59 UTC

Top News

Exxon Lawsuit Against Activist Shareholders Thrown Out -- WSJ

18 cze 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18 cze 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 cze 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 cze 2024, 20:22 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18 cze 2024, 19:59 UTC

Market Talk

Canada Finance Officials Aware of 'Rebalancing' in Labor Market -- Market Talk

18 cze 2024, 19:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 cze 2024, 19:43 UTC

Market Talk

Gold Stays Elevated as Central Banks Continue To Buy -- Market Talk

18 cze 2024, 19:17 UTC

Earnings

Investors Shrugged Off Zyn's Latest Trouble. Nicotine Pouches Still Aren't in the Clear. -- Barrons.com

18 cze 2024, 19:07 UTC

Market Talk

Oil Futures Advance as Traders Bet on Seasonal Demand -- Market Talk

18 cze 2024, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

18 cze 2024, 18:00 UTC

Top News

Amazon Fined by California for Failure to Disclose Worker Quotas -- WSJ

18 cze 2024, 17:17 UTC

Market Talk

Brazil's Central Bank Expected To Pause Easing -- Market Talk

18 cze 2024, 17:12 UTC

Market Talk

U.S. Home Prices Rise At Slowest Rate in Nearly 18 Months -- Market Talk

18 cze 2024, 17:00 UTC

Earnings

Kroger Earnings Due As Grocery Archrivals Walmart, Costco Snatch All-Time Highs -- IBD

18 cze 2024, 16:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

18 cze 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 cze 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 cze 2024, 15:59 UTC

Acquisitions, Mergers, Takeovers

Citi Stock Gains as Bank Showcases an Overlooked Business -- Barrons.com

18 cze 2024, 15:37 UTC

Market Talk

Oil Gains on Expectations of Tighter Market Over Summer -- Market Talk

18 cze 2024, 15:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 cze 2024, 15:35 UTC

Market Talk

German Economic Sentiment Has Plateaued, But Recovery Still on Track -- Market Talk

18 cze 2024, 15:32 UTC

Market Talk

Some Steam Expected to Come Out of Gold Price as Rates Fall -- Market Talk

18 cze 2024, 15:28 UTC

Market Talk

German Economic Sentiment Shrugs off Political Uncertainty -- Market Talk

18 cze 2024, 15:00 UTC

Market Talk

Kering Will Continue to Face Challenges -- Market Talk

18 cze 2024, 14:51 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Proxy ISS Supports BBVA's Bid for Sabadell -- Market Talk

Peer Comparison

Price change

Arbutus Biopharma Corp Forecast

Price Target

By TipRanks

38.89% upside

12 Months Forecast

Average 4.25 USD  38.89%

High 5 USD

Low 4 USD

Based on 4 Wall Street analysts offering 12 month price targets forArbutus Biopharma Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

N/A / 3.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Bullish Evidence